I
The Non Proteolytic Proteasome Inhibitor demonstrated a Proteasome inhibition through a novel mechanism/target. This compound is currently at the lead generation stage.
POC : In-vitro cytotoxicactivity on human cancer cells
A screening platform could be discussed as well
Please contact
Jean-Charles Brosse
e-mail :
mobile : +33607832134
Name | Description |
---|---|
Pharma licensing | Out-licensing (offer) |